A Phase 1b Trial in Patients With Renal Cell Cancer

NCT01258348 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Renal Cell Cancer

Interventions

DRUG: Drug: LY573636-sodium
DRUG: Sunitinib

Sponsor

Eli Lilly and Company